Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.

Katki HA, Schiffman M.

Prev Med. 2018 Feb 14. pii: S0091-7435(18)30040-9. doi: 10.1016/j.ypmed.2018.02.013. [Epub ahead of print]

PMID:
29454079
2.

Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years.

Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE.

Cancer Prev Res (Phila). 2018 Feb 5. pii: canprevres.0293.2017. doi: 10.1158/1940-6207.CAPR-17-0293. [Epub ahead of print]

PMID:
29437696
3.

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M.

J Clin Oncol. 2018 Jan 22:JCO2017753442. doi: 10.1200/JCO.2017.75.3442. [Epub ahead of print]

PMID:
29356609
4.

Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015.

Cheung LC, Katki HA, Chaturvedi AK, Jemal A, Berg CD.

Ann Intern Med. 2018 Feb 6;168(3):229-232. doi: 10.7326/M17-2067. Epub 2018 Jan 2. No abstract available.

PMID:
29297008
5.

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA.

Prev Med. 2017 Dec 6. pii: S0091-7435(17)30482-6. doi: 10.1016/j.ypmed.2017.12.004. [Epub ahead of print]

6.

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M.

Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.

PMID:
29181509
7.

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE.

J Natl Cancer Inst. 2017 Nov 14. doi: 10.1093/jnci/djx225. [Epub ahead of print]

PMID:
29145648
8.

Is the Women's Health Initiative (WHI) Dietary Modification Associated With a Reduced Risk of Pancreatic Cancer?

Stolzenberg-Solomon RZ, Katki HA.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx139. No abstract available.

PMID:
28922785
9.

Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening.

Gu F, Cheung LC, Freedman ND, Katki HA, Caporaso NE.

J Thorac Oncol. 2017 Nov;12(11):1646-1653. doi: 10.1016/j.jtho.2017.08.001. Epub 2017 Aug 14.

PMID:
28818607
10.

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.

Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M.

PLoS One. 2017 Jul 28;12(7):e0182359. doi: 10.1371/journal.pone.0182359. eCollection 2017.

11.

Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.

Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA.

Stat Med. 2017 Sep 30;36(22):3583-3595. doi: 10.1002/sim.7380. Epub 2017 Jun 28.

PMID:
28660629
12.

Why does cervical cancer occur in a state-of-the-art screening program?

Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M.

Gynecol Oncol. 2017 Sep;146(3):546-553. doi: 10.1016/j.ygyno.2017.06.003. Epub 2017 Jun 10.

PMID:
28606721
13.

Sleep Duration across the Adult Lifecourse and Risk of Lung Cancer Mortality: A Cohort Study in Xuanwei, China.

Wong JY, Bassig BA, Vermeulen R, Hu W, Ning B, Seow WJ, Ji BT, Downward GS, Katki HA, Barone-Adesi F, Rothman N, Chapman RS, Lan Q.

Cancer Prev Res (Phila). 2017 Jun;10(6):327-336. doi: 10.1158/1940-6207.CAPR-16-0295. Epub 2017 Apr 4.

14.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

PMID:
28376197
15.

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Obstet Gynecol. 2016 Dec;128(6):1248-1257.

16.

Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.

Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):718-725. doi: 10.1002/ijc.30456. Epub 2016 Oct 17.

17.

Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Gadalla SM, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Katki HA, Lee SJ, Savage SA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2276-2282. doi: 10.1016/j.bbmt.2016.09.012. Epub 2016 Sep 15.

18.

Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.

Chaturvedi AK, D'Souza G, Gillison ML, Katki HA.

Oral Oncol. 2016 Sep;60:61-7. doi: 10.1016/j.oraloncology.2016.06.006. Epub 2016 Jul 8.

PMID:
27531874
19.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA.

Mol Genet Genomic Med. 2016 Mar 20;4(4):475-9. doi: 10.1002/mgg3.220. eCollection 2016 Jul.

20.

Screening: A risk-based framework to decide who benefits from screening.

Castle PE, Katki HA.

Nat Rev Clin Oncol. 2016 Sep;13(9):531-2. doi: 10.1038/nrclinonc.2016.101. Epub 2016 Jun 21. No abstract available.

21.

Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests.

Katki HA, Zhao FH, Hu SY, Zhang Q, Qiao YL, Schiffman M.

Int J Cancer. 2016 Oct 1;139(7):1669. doi: 10.1002/ijc.30192. Epub 2016 Jun 5. No abstract available.

22.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK.

JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.

23.

Cancer risk among the HIV-infected elderly in the United States.

Yanik EL, Katki HA, Engels EA.

AIDS. 2016 Jun 19;30(10):1663-8. doi: 10.1097/QAD.0000000000001077.

24.

Risk assessment to guide cervical screening strategies in a large Chinese population.

Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M.

Int J Cancer. 2016 Jun 1;138(11):2639-47. doi: 10.1002/ijc.30012. Epub 2016 Feb 4.

25.

A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening.

Katki HA, Cheung LC, Fetterman B, Castle PE, Sundaram R.

J R Stat Soc Ser A Stat Soc. 2015 Oct 1;178(4):903-923. Epub 2015 Mar 17.

26.

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):36-42. doi: 10.1158/1055-9965.EPI-15-0669. Epub 2015 Oct 30.

27.

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

Shiels MS, Katki HA, Hildesheim A, Pfeiffer RM, Engels EA, Williams M, Kemp TJ, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2015 Jul 28;107(10). pii: djv199. doi: 10.1093/jnci/djv199. Print 2015 Oct.

PMID:
26220734
28.

Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly.

Yanik EL, Katki HA, Silverberg MJ, Manos MM, Engels EA, Chaturvedi AK.

Cancer Prev Res (Phila). 2015 Sep;8(9):857-63. doi: 10.1158/1940-6207.CAPR-15-0091. Epub 2015 Jul 9.

29.

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.

Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N.

Gynecol Oncol. 2015 Sep;138(3):573-8. doi: 10.1016/j.ygyno.2015.06.040. Epub 2015 Jul 4.

30.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1304-10. doi: 10.1158/1055-9965.EPI-14-1353. Epub 2015 Jun 18.

31.

Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.

Loftfield E, Shiels MS, Graubard BI, Katki HA, Chaturvedi AK, Trabert B, Pinto LA, Kemp TJ, Shebl FM, Mayne ST, Wentzensen N, Purdue MP, Hildesheim A, Sinha R, Freedman ND.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1052-60. doi: 10.1158/1055-9965.EPI-15-0038-T. Epub 2015 May 21.

32.

Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Lang Kuhs KA, Hildesheim A, Trabert B, Kemp TJ, Purdue MP, Wentzensen N, Katki HA, Pinto LA, Loftfield E, Safaeian M, Chaturvedi AK, Shiels MS.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):825-32. doi: 10.1158/1055-9965.EPI-14-1363. Epub 2015 Feb 23.

33.

Response.

Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK.

J Natl Cancer Inst. 2014 Dec 26;107(1):390. doi: 10.1093/jnci/dju390. Print 2015 Jan. No abstract available.

34.

A migrant study of pubertal timing and tempo in British-Bangladeshi girls at varying risk for breast cancer.

Houghton LC, Cooper GD, Bentley GR, Booth M, Chowdhury OA, Troisi R, Ziegler RG, Hoover RN, Katki HA.

Breast Cancer Res. 2014 Nov 15;16(6):469. doi: 10.1186/s13058-014-0469-8.

35.

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.

Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.

J Clin Microbiol. 2015 Jan;53(1):52-9. doi: 10.1128/JCM.02116-14. Epub 2014 Oct 22.

36.

Childhood environment influences adrenarcheal timing among first-generation Bangladeshi migrant girls to the UK.

Houghton LC, Cooper GD, Booth M, Chowdhury OA, Troisi R, Ziegler RG, Katki HA, Hoover RN, Bentley GR.

PLoS One. 2014 Oct 13;9(10):e109200. doi: 10.1371/journal.pone.0109200. eCollection 2014.

37.

Cigarette smoking and variations in systemic immune and inflammation markers.

Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK.

J Natl Cancer Inst. 2014 Oct 1;106(11). pii: dju294. doi: 10.1093/jnci/dju294. Print 2014 Nov.

38.

Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.

Kitahara CM, Trabert B, Katki HA, Chaturvedi AK, Kemp TJ, Pinto LA, Moore SC, Purdue MP, Wentzensen N, Hildesheim A, Shiels MS.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2840-9. doi: 10.1158/1055-9965.EPI-14-0699-T. Epub 2014 Sep 23.

39.

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.

Gage JC, Katki HA, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Castle PE, Kinney WK.

Int J Cancer. 2015 Apr 1;136(7):1665-71. doi: 10.1002/ijc.29143. Epub 2014 Sep 2.

40.

GBV-C infection and risk of NHL among U.S. adults.

Chang CM, Stapleton JT, Klinzman D, McLinden JH, Purdue MP, Katki HA, Engels EA.

Cancer Res. 2014 Oct 1;74(19):5553-60. doi: 10.1158/0008-5472.CAN-14-0209. Epub 2014 Aug 12.

41.

Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology.

Engels EA, Wacholder S, Katki HA, Chaturvedi AK.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1959-64. doi: 10.1158/1055-9965.EPI-14-0282. Epub 2014 Jul 25.

42.

The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.

Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK.

Cancer Cytopathol. 2014 Nov;122(11):842-50. doi: 10.1002/cncy.21463. Epub 2014 Jul 9.

43.

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK.

J Natl Cancer Inst. 2014 Jul 18;106(8). pii: dju153. doi: 10.1093/jnci/dju153. Print 2014 Aug.

44.

Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.

Anderson WF, Rosenberg PS, Katki HA.

J Natl Cancer Inst. 2014 Apr 28;106(5). pii: dju093. doi: 10.1093/jnci/dju093. No abstract available.

45.

A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers.

Kovalchik SA, De Matteis S, Landi MT, Caporaso NE, Varadhan R, Consonni D, Bergen AW, Katki HA, Wacholder S.

BMC Med Res Methodol. 2013 Nov 19;13:143. doi: 10.1186/1471-2288-13-143.

46.

Circulating inflammation markers and prospective risk for lung cancer.

Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.

47.

Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.

Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, Schiller J, Solomon D, Wacholder S, Herrero R, Kreimer AR; Costa Rica Vaccine Trial Group.

J Infect Dis. 2013 Nov 15;208(10):1643-52. doi: 10.1093/infdis/jit369. Epub 2013 Sep 6.

48.

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR; CVT Vaccine Group.

PLoS One. 2013 Jul 17;8(7):e68329. doi: 10.1371/journal.pone.0068329. Print 2013.

49.

Targeting of low-dose CT screening according to the risk of lung-cancer death.

Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA.

N Engl J Med. 2013 Jul 18;369(3):245-254. doi: 10.1056/NEJMoa1301851.

50.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW; 2012 ASCCP Consensus Guidelines Conference.

Obstet Gynecol. 2013 Apr;121(4):829-46. doi: 10.1097/AOG.0b013e3182883a34.

PMID:
23635684

Supplemental Content

Loading ...
Support Center